{
  "data": [
    {
      "variable": "Deaths (at any time)",
      "variable_level": "Deaths (at any time)",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo (Arm A) (N = 351)",
      "raw_stat": "149 (42.5);",
      "source_row": 7,
      "source_col": 2,
      "state_source": "table_body"
    },
    {
      "variable": "Deaths (at any time)",
      "variable_level": "Deaths (at any time)",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo+Ipi (Arm B) (N = 352)",
      "raw_stat": "103 (29.3);",
      "source_row": 7,
      "source_col": 3,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Disease Progression;",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Disease Progression;",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo (Arm A) (N = 351)",
      "raw_stat": "122 (34.8);",
      "source_row": 9,
      "source_col": 2,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Disease Progression;",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Disease Progression;",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo+Ipi (Arm B) (N = 352)",
      "raw_stat": "74 (21.0);",
      "source_row": 9,
      "source_col": 3,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Study Drug Toxicity{a}",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Study Drug Toxicity{a}",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo (Arm A) (N = 351)",
      "raw_stat": "1 (0.3);",
      "source_row": 10,
      "source_col": 2,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Study Drug Toxicity{a}",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Study Drug Toxicity{a}",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo+Ipi (Arm B) (N = 352)",
      "raw_stat": "2 (0.6);",
      "source_row": 10,
      "source_col": 3,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Unknown;",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Unknown;",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo (Arm A) (N = 351)",
      "raw_stat": "7 (2.0);",
      "source_row": 11,
      "source_col": 2,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Unknown;",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Unknown;",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo+Ipi (Arm B) (N = 352)",
      "raw_stat": "10 (2.8);",
      "source_row": 11,
      "source_col": 3,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Other{b}",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Other{b}",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo (Arm A) (N = 351)",
      "raw_stat": "19 (5.4);",
      "source_row": 12,
      "source_col": 2,
      "state_source": "table_body"
    },
    {
      "variable": "\\ \\ \\ \\ Other{b}",
      "variable_level": "\\ \\ Primary Reason for Death; - \\ \\ \\ \\ Other{b}",
      "group1": "TRT",
      "group1_level": "Number (%) of Subjects",
      "group2": "COL2",
      "group2_level": "Nivo+Ipi (Arm B) (N = 352)",
      "raw_stat": "17 (4.8);",
      "source_row": 12,
      "source_col": 3,
      "state_source": "table_body"
    }
  ],
  "metadata": {
    "processing_date": "2025-07-03 19:50:44",
    "stage": "state_parser_stage1",
    "method": "rtf_state_machine",
    "title1": "Protocol: AAZZZ-YYY | \\ | of {{\\*{ NUMPAGES }}}",
    "title2": "Table 8.1-1",
    "title3": "Safety Results - All Treated Subjects in the Nivo+Ipi and Nivo Arms",
    "footnotes": "{a}Deaths considered related to study drug (ie, attributed to study drug toxicity) per investigator: nivo+ipi arm{ }(myocarditis and pneumonitis, 1 case each) and nivo arm (pneumonitis). The 2 deaths in the nivo+ipi arm were{ }previously reported and described in the interim CSR; there were no additional deaths due to study drug toxicity{ }reported in the nivo+ipi arm.{ }{b} The verbatim terms reported for the ;other; reasons for death were consistent with events anticipated in the study{ }population. None were considered related to study drug (per the investigator).{ }{c} Discontinuation of any drug in the regimen.{ }{d} No OESIs were reported in the following categories: demyelination, Guillain-Barre syndrome, graft vs host{ }disease, autoimmune eye disorder, and immune mediated arthritis.{ }MedDRA version 27.0; CTC version 5.0.{ }All events are within 30 days of the last dose of study drug, unless otherwise indicated{ }Source: Table 14.3.2.3.17.1, Table 14.3.2.1.1.1 (death summary), Appendix 16.2.7.4.1 (death listing)"
  },
  "stage": "state_parser_stage1"
}
